Drug Use Investigation For RESCRIPTOR (Regulatory Post Marketing Commitment Plan).
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2010
At a glance
- Drugs Delavirdine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 22 Sep 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 22 Aug 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.